|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
2.780 +0.020 (+0.725%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 811,630 | -9.755% | 899,359 | 655,825 | 737,374 | 323,835 |
| Cost of Sales | (87,018) | -2.114% | (88,897) | (69,181) | (114,680) | (69,125) |
| Gross Profit | 724,612 | -10.593% | 810,462 | 586,644 | 622,694 | 254,710 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,950) | 236.788% | (579) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 197,380 | -3.649% | 204,855 | 162,701 | 183,074 | 57,790 | |
| Taxation | (39,940) | 13.971% | (35,044) | (23,470) | (20,888) | (8,602) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 157,440 | -7.285% | 169,811 | 139,231 | 162,186 | 49,188 | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | (3,410) | -- | 2,406 | 1,190 | 2,251 | (386) |
| Depreciation & Amortisation | 26,480 | -15.169% | 31,215 | 20,495 | 16,416 | 13,192 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 27.740 | -6.662% | 29.720 | 24.210 | 28.120 | 8.510 |
| DPS (cts) | 6.000 | -- | 4.500 | 4.000 | 4.000 | 0.000 |
| Dividend Payout Ratio (%) | 21.629% | -- | 15.141% | 16.522% | 14.225% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.551 | -- | 3.169 | 3.036 | 2.735 | 2.027 |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 157,440,000 |
| %Change | -7.285% |
| EPS / (LPS) | HKD 0.277 |
| NBV Per Share ($) | HKD 3.551 |